This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/mesh/concept/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04527/identifier/chebi/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04527/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04527/identifier/pubchem-compound/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n16http://linked.opendata.cz/resource/drugbank/drug/DB04527/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04527/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04527
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB04527 n10:DB04527
dcterms:title
Beta-Hydroxyasparagine
adms:identifier
n12:DB04527 n13:AHB n14:50789 n15:15991574 n16:46504466
n3:synonym
3-Hydroxyasparagine
n4:hasConcept
n5:M0145193
n3:IUPAC-Name
n7:271B6266-363D-11E5-9242-09173F13E4C5
n3:InChI
n7:271B626C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n7:271B626B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n7:271B6268-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n7:271B6269-363D-11E5-9242-09173F13E4C5
n3:SMILES
n7:271B626A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n7:271B6264-363D-11E5-9242-09173F13E4C5
n3:logP
n7:271B6262-363D-11E5-9242-09173F13E4C5 n7:271B6265-363D-11E5-9242-09173F13E4C5
n3:logS
n7:271B6263-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n7:271B6272-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n7:271B6273-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n7:271B626D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n7:271B626E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n7:271B6270-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n7:271B626F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n7:271B6271-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
16712-79-1
n3:Bioavailability
n7:271B6278-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n7:271B627A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n7:271B627B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n7:271B6277-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n7:271B6276-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n7:271B6279-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n7:271B6267-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n7:271B6274-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n7:271B6275-363D-11E5-9242-09173F13E4C5